Landing Point Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Landing Point Financial Group's LLY Position: Q1 2026 in Review
Landing Point Financial Group reduced its Eli Lilly (LLY) stake by 2.6% in Q1 2026, selling an estimated $17.2K and leaving 628 shares worth $577K. The position accounts for 0.28% of the portfolio, ranked #44.
Landing Point Financial Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $694K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Landing Point Financial Group held 628 shares of Eli Lilly worth $577K as of Q1 2026.
- Landing Point Financial Group sold 17 Eli Lilly shares in Q1 2026, an estimated $17.2K.
- Eli Lilly made up 0.28% of Landing Point Financial Group's portfolio in Q1 2026, its #44 holding.
- Landing Point Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Landing Point Financial Group's Eli Lilly position peaked at $694K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Landing Point Financial Group's 13F filing for Q1 2026, filed 5 May 2026.